Back to Search Start Over

Preparation of paeoniflorin-glycyrrhizic acid complex transethosome gel and its preventive and therapeutic effects on melasma.

Authors :
Xiao, Yaoyao
Zhou, Lele
Tao, Wenkang
Yang, Xuan
Li, Junying
Wang, Rulin
Zhao, Yanan
Peng, Can
Zhang, Caiyun
Source :
European Journal of Pharmaceutical Sciences. Jan2024, Vol. 192, pN.PAG-N.PAG. 1p.
Publication Year :
2024

Abstract

Paeoniflorin (PF) and glycyrrhizic acid (GL) have skin beautifying effects of anti-inflammation, anti-oxidation, inhibition of melanin formation, and reduction of skin pigmentation. To improve the transdermal permeability of PF and GL in transdermal drug delivery system (TDDS) and enhance their anti-melasma efficacy, PF-GL transethosome (PF-GL-TE) was prepared by ethanol injection method, and finally gelled with carbomer-940 to form PF-GL-TE gel. Consequently, the obtained PF-GL-TE is small and uniform, with an average particle size and a PDI value of about 167.9 nm and 0.102. PF-GL-TE gel showed sustained release behavior and high transdermal permeability in vitro release and transdermal tests. Meanwhile, PF-GL-TE gel played significant preventive effects on melasma induced by progesterone injection and ultraviolet radiation B (UVB) irradiation. According to the results of H&E staining and Masson staining of rat skin, PF-GL-TE gel can alleviate the skin inflammation of and reduce the loss of collagen fibers of back skin in the melasma model rats. Compared with the PF-GL mixture gel, PF-GL-TE gel significantly attenuated the oxidative damage of liver and skin by increasing the activity of SOD and reducing the content of MDA. The results of Western blot showed that PF-GL-TE gel might down-regulate melanin-related proteins expressions of MITF/TYR/TRP1 and TRP2 to prevent and treat melasma. These findings indicate that PF-GL-TE gel is an effective TDDS for delivering PF and GL into the skin, providing a promising preparation for effective prevention and treatment of melasma. [Display omitted] [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
09280987
Volume :
192
Database :
Academic Search Index
Journal :
European Journal of Pharmaceutical Sciences
Publication Type :
Academic Journal
Accession number :
174317920
Full Text :
https://doi.org/10.1016/j.ejps.2023.106664